Webcasts

Novel approach to automating Maxi-, Mega-, and Giga-plasmid DNA preparations

Broadcast 1 (APAC): Thursday December 2, 2021 at 10:00am CST | 11:00am JST Broadcast 2 (EMEA): Thursday December 2, 2021 at 2:00pm GMT | 1:00pm CET Broadcast 3 (Americas): Thursday December 2, 2021 at 2pm EST | 1pm CST | 11am PST Interested in automating your plasmid purification work? Learn how you can automate your Maxi, Mega and Giga preparations with consistent purity and transfection efficiency

**Wednesday, October 27, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST** Freezing and thawing at scale of API and BDS biologics is not routine and should be handled with the consideration given to any critical unit operation. This webinar highlights key protein related quality challenges associated with freeze methods. Optimization thorough model freeze/thaw studies are presented.

Wednesday, October 6, 2021 at 12pm EDT | 9am PDT | 5pm BST | 6pm CEST In this webinar, you will learn about the possibility of GMP method transfer for HCP assays leveraging a robust and automated workflow based on combining data-dependent and data-independent mass spectrometry. A study of data from multiple projects over three years demonstrated the robustness and reproducibility of the method.

Wednesday, September 29, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Learn about strategies for inline process analytics aimed at automated feed control in an upstream bioprocess. Using the example of a Raman analyzer, a glucose analyzer, and an exhaust analyzer experts demonstrate how to achieve seamless sensor integration with the bioprocess control software.

Vector in HyPerforma Single-Use Bioreactors (S.U.B.s) using ExpiSf Expression System

Thursday, September 16, 2021at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Thermo Scientific HyPerforma Single Use Bioreactors (S.U.B.s) are widely used in the biopharma industry and can be used for a broad range of processes. With the rapid growth of the viral vector gene therapy industry, having a trusted partner is crucial to the success of scaling these processes. This webinar focuses on the scalability of both the HyPerforma 5:1 S.U.B. and the HyPeforma DynaDrive S.U.B. for growth and transfection of ExpiSf insect cells for adeno-associated virus vector production.

Thursday, August 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Developing a robust, transferable size-exclusion chromatography (SEC) method for routine testing of mabs and other biotherapeutics can be challenging. Join us for this presentation to learn about SEC method development, with an emphasis on method transfer and sustainability.

Tuesday, July 13, 2021 at 10am EDT | 3pm BST | 4pm CEST Biopharmaceuticals or biologics are a diverse class of compounds that need special attention from discovery, CQAs analysis, manufacturing and QC. Liquid Chromatography is an essential tool for structure characterization, PTM, glycan analysis and quality control of biopharmaceuticals. In this webinar, speakers will discuss the current challenges analytical laboratories face when manufacturing or analyzing biologics and how the hurdles of compromised sample integrity, process analytical integration, and surface interaction may be overcome. Whether analyzing large biomolecules, mAbs, intact proteins, oligonucleotides, aggregates, charge variants, ADCs, peptides, glycans or spent media, there is something for everyone.

Why Flexible End-to-End Solutions Succeed in BDS Handling

*Thursday, May 27, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* Transportation of your bulk drug substance (BDS) from downstream to the fill/finish site might not be as simple as it sounds. Mostly geographically detached, each batch of BDS is filled into different primary packaging, frozen to sub-zero temperatures, stored, and shipped before it is then thawed and drained at the fill/finish site. *On Demand Until May 27, 2022*

Bridging the Digital Divide to Advance Bio/Pharma Manufacturing and Quality: A Technology Forum

*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*

Method Development Strategies for Purity Analysis of Proteins by Intact and Subunit Analysis

***Live: Monday, May 24, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Join us to learn best practices in method development for intact and subunit purity analysis for mAbs by reversed-phase liquid chromatography (RPLC), including how to best adjust method parameters such as temperature, gradient slope, and flow rate to obtain high-quality impurity profiling and ensure method robustness and reproducibility. ***On Demand until May 24, 2022***

Single-Use Material Selection for Critical Storage Operations in Gene Therapy Development and Scale-up

*Wednesday, May 19, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* The selection of single-use materials for novel gene therapies, as well as the material’s commercial viability, is crucial especially for those used in storage and cryogenic operations. Learn about key product contact material and process compatibility requirements during this webcast. *On Demand Until May 19, 2022*

Process Analytical Technology (PAT): Online Monitoring and Control of Upstream Titer, Product Quality and Amino Acid Content Using 2D-LC with SegFlow Interface-Use Material Selection for Critical Storage Operations in Gene Therapy Development and Scale-up

*Europe Broadcast: Tuesday, May 18, 2021 9am EDT | 2pm BST | 3pm CEST and US Broadcast: Tuesday, May 18, 2021 2pm EDT | 1pm CDT | 11am PDT* Biopharmaceutical companies are transitioning from “quality-by-testing” philosophy to “quality-by-design” paradigms, and establishing QbD-based PAT tools to increase product and process understanding. Due to the deficit of analytical methods to support QbD-driven continuous bioprocessing, biopharmaceutical companies are actively developing PAT tools to comply with QbD regulations. *On Demand Until May 18, 2022*